Viewing Study NCT05503212


Ignite Creation Date: 2025-12-26 @ 11:09 AM
Ignite Modification Date: 2025-12-31 @ 11:01 PM
Study NCT ID: NCT05503212
Status: COMPLETED
Last Update Posted: 2023-08-14
First Post: 2022-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions
Sponsor: Centre Hospitalier Universitaire Vaudois
Organization:

Study Overview

Official Title: Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral : the BRAVO Retrospective Analysis
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BRAVO
Brief Summary: Isolated vertebral artery occlusions (VAO) account for approximately one third of posterior circulation occlusions, but have been given the least attention among posterior circulation strokes. If the two recent ATTENTION and BAOCHE randomized clinical trials have proven the superiority of endovascular thrombectomy (EVT) in basilar artery occlusions, data on the effectiveness and harm of acute revascularization treatment on isolated VAO is scarce. We aim to investigate the impact of acute recanalisation treatments in acute ischemic stroke patients with isolated VAO.

In the absence of RCT, observational data with appropriate statistical methods may give indications on benefits and harms of treating neglected stroke situations like acute vertebral occlusion. Results may also lay the basis for prospective studies, such as randomized clinical trials.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: